Literature DB >> 30276446

Sex-related factors in autoimmune liver diseases.

Dorothee Schwinge1, Christoph Schramm2,3.   

Abstract

Autoimmune diseases are a broad range of diseases in which the immune system produces an inappropriate response to self-antigens. This results in inflammation, damage, or dysfunction of tissues and/or organs. Many autoimmune diseases are more common in women and differences between female and male immune and autoimmune responses have been well documented. In general, most of the autoimmune diseases seem to affect more females, although there are exceptions. Autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC) are considered to be autoimmune liver diseases (AILD). They all are rare diseases and they result in significant morbidity and mortality. The female predominance in PBC and AIH are among the strongest among autoimmune diseases. However, the mechanisms responsible for the sex differences in autoimmune liver diseases are largely unknown. In this review, we discuss the recent findings on the influence of sex-dependent mechanisms, which may contribute to differences in presentation, clinical characteristics, disease course, and complications observed between female and male patients with autoimmune liver disease.

Entities:  

Keywords:  Autoimmune hepatitis (AIH); Cholangitis; Estradiol; Microbiome; Pregnancy; Primary biliary cholangitis (PBC); Primary sclerosing; Testosterone; X Chromosome

Year:  2018        PMID: 30276446     DOI: 10.1007/s00281-018-0715-8

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  130 in total

Review 1.  Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.

Authors:  Kirsten Boonstra; Ulrich Beuers; Cyriel Y Ponsioen
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

Review 2.  Primary sclerosing cholangitis - a comprehensive review.

Authors:  Tom H Karlsen; Trine Folseraas; Douglas Thorburn; Mette Vesterhus
Journal:  J Hepatol       Date:  2017-08-10       Impact factor: 25.083

3.  Female preponderance of primary biliary cholangitis is all about our understanding of its autoimmune nature.

Authors:  Marco Carbone; Giulia Bonato; Pietro Invernizzi
Journal:  Hepatology       Date:  2018-02-19       Impact factor: 17.425

4.  Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.

Authors:  Jordan J Feld; Huong Dinh; Tamara Arenovich; Victoria A Marcus; Ian R Wanless; E Jenny Heathcote
Journal:  Hepatology       Date:  2005-07       Impact factor: 17.425

5.  Intracellular pathways mediating estrogen-induced cholangiocyte proliferation in the rat.

Authors:  Domenico Alvaro; Paolo Onori; Veronica Drudi Metalli; Gianluca Svegliati-Baroni; Franco Folli; Antonio Franchitto; Gianfranco Alpini; Maria Grazia Mancino; Adolfo Francesco Attili; Eugenio Gaudio
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

6.  Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.

Authors:  D Kevans; A D Tyler; K Holm; K K Jørgensen; M H Vatn; T H Karlsen; G G Kaplan; B Eksteen; D Gevers; J R Hov; M S Silverberg
Journal:  J Crohns Colitis       Date:  2015-11-02       Impact factor: 9.071

Review 7.  Role of the bicarbonate-responsive soluble adenylyl cyclase in cholangiocyte apoptosis in primary biliary cholangitis; a new hypothesis.

Authors:  Jung-Chin Chang; Simei Go; Arthur J Verhoeven; Ulrich Beuers; Ronald P J Oude Elferink
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-09-28       Impact factor: 5.187

Review 8.  Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Clin Gastroenterol Hepatol       Date:  2008-03-07       Impact factor: 11.382

9.  DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis.

Authors:  Ana Lleo; Weici Zhang; Ming Zhao; Yixin Tan; Pietro Invernizzi; Qianjin Lu; M Eric Gershwin; Francesca Bernuzzi; Bochen Zhu; Qian Liu; Qiqun Tan; Federica Malinverno; Luca Valenti; Tingting Jiang; Lina Tan; Wei Liao; Ross Coppel; David H Adams
Journal:  Clin Epigenetics       Date:  2015-07-07       Impact factor: 6.551

10.  Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.

Authors:  João Sabino; Sara Vieira-Silva; Kathleen Machiels; Marie Joossens; Gwen Falony; Vera Ballet; Marc Ferrante; Gert Van Assche; Schalk Van der Merwe; Severine Vermeire; Jeroen Raes
Journal:  Gut       Date:  2016-05-20       Impact factor: 23.059

View more
  10 in total

1.  Sex differences in immunity.

Authors:  Hanna Lotter; Marcus Altfeld
Journal:  Semin Immunopathol       Date:  2019-02-11       Impact factor: 9.623

2.  Redox regulation of hepatic NLRP3 inflammasome activation and immune dysregulation in trichloroethene-mediated autoimmunity.

Authors:  Hui Wang; Gangduo Wang; Yuejin Liang; Xiaotang Du; Paul J Boor; Jiaren Sun; M Firoze Khan
Journal:  Free Radic Biol Med       Date:  2019-08-13       Impact factor: 7.376

Review 3.  Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events.

Authors:  Yoshiyuki Nakamura
Journal:  Front Med (Lausanne)       Date:  2019-05-29

4.  Estrogen negatively regulates the renal epithelial sodium channel (ENaC) by promoting Derlin-1 expression and AMPK activation.

Authors:  Xue Zhang; Yamei Ge; Ashfaq-Ahmad-Shah Bukhari; Qian Zhu; Yachen Shen; Min Li; Hui Sun; Dongming Su; Xiubin Liang
Journal:  Exp Mol Med       Date:  2019-05-21       Impact factor: 8.718

Review 5.  The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors.

Authors:  Xiao-Hui Jia; Lu-Ying Geng; Pan-Pan Jiang; Hong Xu; Ke-Jun Nan; Yu Yao; Li-Li Jiang; Hong Sun; Tian-Jie Qin; Hui Guo
Journal:  J Exp Clin Cancer Res       Date:  2020-12-14

6.  Autoimmune Hepatitis with Elevated Serum IgG4 Levels Have a High Prevalence of Cirrhosis at Diagnosis.

Authors:  Mei Xue; Yi Shen; Xiaoli Fan; Mengyi Shen; Li Yang
Journal:  Can J Gastroenterol Hepatol       Date:  2021-01-04

Review 7.  Concanavalin A-induced autoimmune hepatitis model in mice: Mechanisms and future outlook.

Authors:  Yang Liu; Huiqin Hao; Tiezheng Hou
Journal:  Open Life Sci       Date:  2022-02-28       Impact factor: 0.938

8.  Effect of LncRNA XIST on Immune Cells of Primary Biliary Cholangitis.

Authors:  Chunhui She; Yifei Yang; Bo Zang; Yuan Yao; Qixuan Liu; Patrick S C Leung; Bin Liu
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 8.786

9.  Relationship between osteoporosis, sarcopenia, vertebral fracture, and osteosarcopenia in patients with primary biliary cholangitis.

Authors:  Chisato Saeki; Tsunekazu Oikawa; Tomoya Kanai; Masanori Nakano; Yuichi Torisu; Nobuyuki Sasaki; Masahiro Abo; Masayuki Saruta; Akihito Tsubota
Journal:  Eur J Gastroenterol Hepatol       Date:  2021-05-01       Impact factor: 2.586

10.  Biomarkers Associated with Immune-Related Adverse Events under Checkpoint Inhibitors in Metastatic Melanoma.

Authors:  Marcus Wölffer; Florian Battke; Martin Schulze; Magdalena Feldhahn; Lukas Flatz; Peter Martus; Andrea Forschner
Journal:  Cancers (Basel)       Date:  2022-01-08       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.